Contineum Therapeutics, Inc. (CTNM)Healthcare | Biotechnology | San Diego, United States | NasdaqGS
14.62 USD
-0.57
(-3.752%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 14.62 |
Hot Take ↕ | July 11, 2026, 3:54 a.m. EDT
The investment case here is fractured by a brutal reality check. Despite a 'strong buy' analyst consensus and a lofty $28 price target, the actual market verdict is starkly different: the stock has erased over 81% of its value in just one year, dropping from $21 to roughly $4 before a recent, volatile rebound to $15. This massive drawdown, combined with negative earnings, negative free cash flow, and a deteriorating return on equity, signals a business in distress rather than a hidden gem. The recent price action shows a sharp rally followed by a pullback, leaving the stock hovering near its 50-day average but still far below its yearly peak. Crucially, insiders are actively selling; both the CEO and CSO have executed significant share sales recently, which often acts as a warning light when management believes the stock is overvalued or lacks immediate catalysts. While the biotech sector can be volatile, the combination of a collapsing price trajectory, negative fundamentals, and insider distribution makes this a dangerous hold for now. The lack of a dividend provides no cushion, and the heavy put options activity confirms that retail and institutional traders are bracing for further pain. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.073586 |
| AutoTheta | 0.075521 |
| AutoETS | 0.075526 |
| AutoARIMA | 0.075936 |
| MSTL_57 | 0.091755 |
| MSTL_94 | 0.153471 |
| MSTL_57_94 | 0.268127 |
Forecast horizon: 60 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 3.82 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.560 |
| Excess Kurtosis | -0.64 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.781 |
| Market Cap | 546,588,800 |
| Forward P/E | -8.06 |
| Beta | 0.70 |
| Website | https://www.contineum-tx.com |
As of July 11, 2026, 3:54 a.m. EDT: Speculators are heavily positioned for downside protection, with massive open interest in out-of-the-money puts (340 contracts vs negligible calls) expiring in July. While some call volume exists for August and October targets above $20, the overwhelming skew toward deep out-of-the-money puts suggests a fear of a continued collapse or a 'catapult' scenario where investors are hedging against further losses rather than betting on a recovery.
| Attribute | Value |
|---|---|
| 52 Week Change | 3.0723863 |
| Address1 | 3,565 General Atomics Court |
| Address2 | Suite 200 |
| All Time High | 22.0 |
| All Time Low | 3.35 |
| Ask | 18.67 |
| Ask Size | 2 |
| Average Analyst Rating | 1.4 - Strong Buy |
| Average Daily Volume10 Day | 773,640 |
| Average Daily Volume3 Month | 331,429 |
| Average Volume | 331,429 |
| Average Volume10Days | 773,640 |
| Beta | 0.703 |
| Bid | 10.88 |
| Bid Size | 2 |
| Book Value | 6.688 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 14.62 |
| Current Ratio | 38.0 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 15.2655 |
| Day Low | 14.46 |
| Debt To Equity | 2.781 |
| Display Name | Contineum Therapeutics |
| Earnings Timestamp End | 1,785,960,000 |
| Earnings Timestamp Start | 1,785,960,000 |
| Ebitda | -66,525,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -4.618 |
| Enterprise Value | 307,214,816 |
| Eps Current Year | -1.64714 |
| Eps Forward | -1.81429 |
| Eps Trailing Twelve Months | -1.94 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 13.4456 |
| Fifty Day Average Change | 1.1744003 |
| Fifty Day Average Change Percent | 0.08734459 |
| Fifty Two Week Change Percent | 307.23862 |
| Fifty Two Week High | 16.91 |
| Fifty Two Week High Change | -2.29 |
| Fifty Two Week High Change Percent | -0.13542283 |
| Fifty Two Week Low | 3.72 |
| Fifty Two Week Low Change | 10.9 |
| Fifty Two Week Low Change Percent | 2.9301074 |
| Fifty Two Week Range | 3.72 - 16.91 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,712,323,800,000 |
| Float Shares | 27,588,529 |
| Forward Eps | -1.81429 |
| Forward P E | -8.0582485 |
| Free Cashflow | -39,011,124 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 51 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.009649999 |
| Held Percent Institutions | 0.94114 |
| Implied Shares Outstanding | 37,386,377 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,024-04-05 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company's lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California. |
| Long Name | Contineum Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 546,588,800 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_558548528 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -58,444,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 567,899,066 |
| Number Of Analyst Opinions | 6 |
| Open | 15.11 |
| Operating Cashflow | -57,166,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 858 333 5280 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 14.62 |
| Post Market Time | 1,783,974,306 |
| Previous Close | 15.19 |
| Price Eps Current Year | -8.875991 |
| Price Hint | 2 |
| Price To Book | 2.1860046 |
| Profit Margins | 0.0 |
| Quick Ratio | 37.003 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.42857 |
| Region | US |
| Regular Market Change | -0.57 |
| Regular Market Change Percent | -3.75247 |
| Regular Market Day High | 15.2655 |
| Regular Market Day Low | 14.46 |
| Regular Market Day Range | 14.46 - 15.2655 |
| Regular Market Open | 15.11 |
| Regular Market Previous Close | 15.19 |
| Regular Market Price | 14.62 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 257,334 |
| Return On Assets | -0.18181999 |
| Return On Equity | -0.26883 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 32,723,877 |
| Shares Percent Shares Out | 0.0572 |
| Shares Short | 2,137,692 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,431,603 |
| Short Name | Contineum Therapeutics, Inc. |
| Short Percent Of Float | 0.0657 |
| Short Ratio | 4.61 |
| Source Interval | 15 |
| State | CA |
| Symbol | CTNM |
| Target High Price | 28.0 |
| Target Low Price | 16.0 |
| Target Mean Price | 22.33333 |
| Target Median Price | 22.0 |
| Total Cash | 246,328,000 |
| Total Cash Per Share | 6.589 |
| Total Debt | 6,954,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.94 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 12.679325 |
| Two Hundred Day Average Change | 1.9406748 |
| Two Hundred Day Average Change Percent | 0.1530582 |
| Type Disp | Equity |
| Volume | 257,334 |
| Website | https://www.contineum-tx.com |
| Zip | 92,121 |